V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008417 | 190004657 | 1.79 | 42 | null | 2017-09-02 | 2018-05-08 | OST Euramos 1 Closed Trial - IE | N | N | TRIAL UNSPECIFIED | 100275307 |
| 190008418 | 190004658 | 1.9 | 89.8 | Adjuvant (A) | 2017-09-10 | 2017-09-11 | IMATINIB | 02 | N | LANREOTIDE | 101304624 |
| 190008419 | 190004659 | 1.73 | 103.8 | Palliative (P) | 2021-01-13 | 2021-01-17 | EP | 02 | Y | CISPLATIN + GEMCITABINE | 101356203 |
| 190008423 | 190004660 | 1.47 | 11.5 | null | 2020-03-03 | 2020-03-24 | OST Rel Ifosfamide Etoposide Mtx | 02 | N | LANREOTIDE | 100969447 |
| 190008425 | 190004661 | 1.78 | 53.7 | null | 2020-07-13 | 2020-07-14 | CISPLATIN + RT | 01 | Y | CISPLATIN | 100064611 |
| 190008426 | 190004662 | null | 34 | Palliative (P) | 2018-09-01 | 2018-09-01 | OST Euramos 1 Closed Trial - Ai | N | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 101569858 |
| 190008428 | 190004663 | 1.61 | 75.3 | null | 2018-10-27 | 2018-11-23 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | LIPOSOMAL DOXORUBICIN | 100505133 |
| 190008430 | 190004664 | 1.47 | 98.1 | Curative (C) | 2019-11-03 | 2019-11-03 | Trabectedin | 02 | null | TRIAL UNSPECIFIED | 100274128 |
| 190008431 | 190004665 | 1.65 | 67.3 | null | 2017-07-23 | 2017-07-28 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CARBOPLATIN + ETOPOSIDE | 100987136 |
| 190008436 | 190004666 | 1.82 | 41 | Palliative (P) | null | 2019-10-03 | MAP | 02 | N | ABIRATERONE | 100827736 |
| 190008438 | 190004667 | 1.47 | 79.7 | null | 2019-08-03 | 2019-08-08 | CARBOPLATIN + RT | 02 | N | CARBOPLATIN | 101648291 |
| 190008439 | 190004668 | 1.52 | 55.8 | null | 2020-10-21 | 2021-04-10 | Bleomycin + Cisplatin + Vinblastine | 02 | N | NAB-PACLITAXEL | 100172726 |
| 190008440 | 190004669 | 1.65 | 50.75 | Curative (C) | 2019-02-17 | 2019-03-07 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | CAPECITABINE | 101070314 |
| 190008443 | 190004670 | 1.67 | 74.6 | Palliative (P) | 2019-06-06 | 2019-07-02 | Carboplatin AUC 6 - 10 | N | Y | CARBOPLATIN | 101739037 |
| 190008455 | 190004671 | 1.76 | null | 02 | 2016-03-19 | 2016-04-14 | Doxorubicin + Ifosfamide | 01 | N | EPIRUBICIN | 101729167 |
| 190008471 | 190004672 | null | null | Neo-adjuvant (N) | null | 2017-10-19 | EW Rel Irinotecan & Temozolomide | null | null | FULVESTRANT + RIBOCICLIB | 101383689 |
| 190008472 | 190004673 | 1.87 | 44.8 | Neo-adjuvant (N) | 2017-10-30 | 2017-11-05 | Imatinib 400mg | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100406473 |
| 190008474 | 190004674 | 1.68 | 104.2 | Curative (C) | 2019-07-11 | 2019-08-13 | DOXORUBICIN + METHOTREXATE | 02 | N | PACLITAXEL | 101674078 |
| 190008475 | 190004675 | null | 65.9 | Curative (C) | null | 2017-06-18 | Oxaliplatin + Modified de Gramont | 02 | N | CARBOPLATIN + GEMCITABINE | 101600308 |
| 190008478 | 190004676 | 0 | 28.8 | null | 2019-04-17 | 2019-05-08 | Dacarbazine | 02 | N | LIPOSOMAL DOXORUBICIN | 100849850 |
| 190008481 | 190004677 | 1.09 | 77.1 | Curative (C) | 2016-07-24 | 2016-07-27 | CARBOPLATIN + PACLITAXEL | 01 | null | CARBOPLATIN + PACLITAXEL | 100943515 |
| 190008482 | 190004678 | 1.63 | 52.35 | Palliative (P) | 2017-10-11 | 2017-10-27 | ATEZOLIZUMAB + CARBOPLATIN + ETOPOSIDE | N | N | CAPECITABINE + GEMCITABINE | 100200593 |
| 190008489 | 190004679 | 0 | 54.1 | Adjuvant (A) | null | 2019-01-06 | PEMBROLIZUMAB | 02 | N | PACLITAXEL | 100544585 |
| 190008490 | 190004680 | 1.69 | 48.8 | Curative (C) | 2017-05-15 | 2017-05-17 | Trial Unspecified | N | N | DOXORUBICIN + OLARATUMAB | 100139618 |
| 190008493 | 190004681 | 1.52 | 61.7 | Curative (C) | null | 2016-01-21 | BUSULFAN + MELPHALAN | 02 | null | CAPECITABINE + OXALIPLATIN | 100458943 |
| 190008496 | 190004682 | 1.68 | 33 | null | null | 2019-07-26 | MAP + MIFAMURTIDE | 01 | null | BEP | 100687980 |
| 190008508 | 190004683 | 1.56 | 60 | Palliative (P) | 2019-08-10 | 2019-08-10 | CAPECITABINE + CARBOPLATIN | N | N | ABIRATERONE | 100070073 |
| 190008512 | 190004684 | 1.61 | 77.9 | null | 2016-08-30 | 2016-09-06 | EURAMOS TRIAL | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100893307 |
| 190008513 | 190004685 | 1.63 | 64.8 | null | 2019-09-04 | 2019-09-04 | FLUOROURACIL + IRINOTECAN | 02 | N | NIVOLUMAB | 101214282 |
| 190008515 | 190004686 | 1.7 | null | Palliative (P) | null | 2019-08-09 | NIVOLUMAB | null | null | OXALIPLATIN + MDG | 100152508 |
| 190008516 | 190004687 | 1.76 | null | Palliative (P) | 2016-02-24 | 2016-07-20 | Cyclophosphamide + Topotecan | 02 | null | FLUOROURACIL + OXALIPLATIN | 101731513 |
| 190008521 | 190004688 | 1.83 | 26.3 | null | 2022-03-05 | 2022-03-05 | Carboplatin + Etoposide iv&po | 02 | N | PACLITAXEL | 100232513 |
| 190008529 | 190004689 | 1.68 | 77.9 | Palliative (P) | null | 2018-04-24 | STS Rhabdo VIT0910 Vinc Irino Temoz | null | null | FLUOROURACIL + OXALIPLATIN | 101165907 |
| 190008535 | 190004690 | 1.76 | 44.9 | Palliative (P) | 2019-12-05 | 2019-12-05 | GemCarbo Days 1+8 | 02 | N | FLUOROURACIL + OXALIPLATIN | 100902655 |
| 190008538 | 190004691 | 1.52 | 82.85 | Palliative (P) | null | 2019-05-22 | Paclitaxel (2 or 3 weekly) | 02 | null | TRIAL | 100795070 |
| 190008545 | 190004692 | 1.57 | 77.35 | Palliative (P) | 2017-08-16 | 2017-08-23 | Trial Unspecified | 02 | null | CNS ATRT METHOTREXATE INTRATHECAL | 101346301 |
| 190008553 | 190004693 | 1.78 | 92.2 | Neo-adjuvant (N) | 2019-01-13 | 2019-02-11 | EW EuroEwing 2012 Arm A VIDE | 02 | N | CETUXIMAB | 101151809 |
| 190008561 | 190004694 | 1.79 | 54.5 | Palliative (P) | 2017-10-28 | 2017-11-22 | GemCarbo Days 1+8 | 2 | Y | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101126629 |
| 190008563 | 190004695 | 1.49 | 74 | Neo-adjuvant (N) | 2021-02-26 | 2021-03-19 | EW EuroEwing 2012 Arm A VIDE | null | null | CAPECITABINE + CARBOPLATIN | 101063328 |
| 190008567 | 190004696 | 1.76 | 67.4 | Palliative (P) | 2017-03-22 | 2017-03-24 | Gemcitabine day 1&8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100150432 |
| 190008570 | 190004697 | 1.72 | 58.3 | Curative (C) | null | 2017-12-01 | Cisplatin 7 day | 02 | N | CISPLATIN | 101455787 |
| 190008572 | 190004698 | 1.6 | 86 | Neo-adjuvant (N) | 2017-12-14 | 2017-12-27 | Enzalutamide | N | Y | FLUOROURACIL + OXALIPLATIN | 101317442 |
| 190008575 | 190004699 | 1.5 | 88 | null | 2018-04-11 | 2018-04-11 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | N | CARBOPLATIN + FLUOROURACIL | 101320016 |
| 190008579 | 190004700 | 1.65 | 75 | Neo-adjuvant (N) | 2021-11-05 | 2021-11-12 | STS Rhabdomyosarcoma RMS 2005 IVAVV | Y | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 101327356 |
| 190008586 | 190004701 | 1.81 | 89.8 | null | 2018-06-23 | 2018-07-17 | Cisplatin 7 day | 02 | N | CISPLATIN | 100356929 |
| 190008589 | 190004702 | 1.53 | 62.1 | Palliative (P) | 2018-06-13 | 2018-07-03 | Capecitabine + Oxaliplatin 21day | 02 | null | CETUXIMAB + CISPLATIN + FLUOROURACIL | 100851072 |
| 190008608 | 190004703 | 1.8 | 70 | Curative (C) | 2018-06-22 | 2018-11-02 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | N | CISPLATIN + FLUOROURACIL | 100150733 |
| 190008609 | 190004704 | 1.61 | 55 | Adjuvant (A) | 2018-08-04 | 2018-08-18 | OST Mifamurtide | 02 | null | CARBOPLATIN + RT | 101054051 |
| 190008610 | 190004705 | 1.79 | 56.4 | Neo-adjuvant (N) | 2020-03-11 | 2020-03-11 | EW Rel rEECur Irinotecan/Temozolomide | 02 | Y | FLUOROURACIL + IRINOTECAN | 101047466 |
| 190008614 | 190004706 | 0 | 43 | null | 2019-09-03 | 2020-03-28 | Trial Unspecified | 2 | null | NIVOLUMAB | 100353650 |